Tracking a skin disease treatment in everyday practice
NCT ID NCT06517732
First seen Dec 16, 2025 · Last updated Apr 17, 2026 · Updated 20 times
Summary
This study aims to understand how well the drug secukinumab works for adults with moderate to severe hidradenitis suppurativa (HS) in real-world Russian clinics. Researchers will observe 107 patients already prescribed this medication by their doctors as part of normal care. The goal is to collect data on treatment effectiveness, side effects, and how the drug is used alongside other treatments or surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Izhevsk, 426039, Russia
-
Novartis Investigative Site
Kaliningrad, 236016, Russia
-
Novartis Investigative Site
Kaliningrad, 236029, Russia
-
Novartis Investigative Site
Kazan', 420012, Russia
-
Novartis Investigative Site
Kemerovo, 650025, Russia
-
Novartis Investigative Site
Krasnodar, 350020, Russia
-
Novartis Investigative Site
Moscow, 107076, Russia
-
Novartis Investigative Site
Moscow, 119881, Russia
-
Novartis Investigative Site
Moscow, 123182, Russia
-
Novartis Investigative Site
Moscow, 129110, Russia
-
Novartis Investigative Site
Nizhny Novgorod, 603950, Russia
-
Novartis Investigative Site
Penza, 440052, Russia
-
Novartis Investigative Site
Saint Petersburg, 197022, Russia
-
Novartis Investigative Site
Samara, 443079, Russia
-
Novartis Investigative Site
Saratov, 410028, Russia
-
Novartis Investigative Site
Stavropol, 355020, Russia
-
Novartis Investigative Site
Tula, 300053, Russia
-
Novartis Investigative Site
Ufa, 450010, Russia
-
Novartis Investigative Site
Yakutsk, 677000, Russia
Conditions
Explore the condition pages connected to this study.